Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-04

Clinical Trial Update: B Cell Lymphocyte in Humoral Rejection and Alloimmunisation

View source ↗

Summary

Clinical trial update examining the role of B cells in humoral rejection and alloimmunisation in renal transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Brest | Conditions: Renal Transplant | Status: UNKNOWN